BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26239118)

  • 1. DNAJB1 negatively regulates MIG6 to promote epidermal growth factor receptor signaling.
    Park SY; Choi HK; Seo JS; Yoo JY; Jeong JW; Choi Y; Choi KC; Yoon HG
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2722-30. PubMed ID: 26239118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I γ Phosphatidylinositol Phosphate 5-Kinase i5 Controls the Ubiquitination and Degradation of the Tumor Suppressor Mitogen-inducible Gene 6.
    Sun M; Cai J; Anderson RA; Sun Y
    J Biol Chem; 2016 Oct; 291(41):21461-21473. PubMed ID: 27557663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations.
    Endo H; Okami J; Okuyama H; Nishizawa Y; Imamura F; Inoue M
    Oncogene; 2017 May; 36(20):2824-2834. PubMed ID: 27893711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6.
    Menezes SV; Kovacevic Z; Richardson DR
    J Biol Chem; 2019 Mar; 294(11):4045-4064. PubMed ID: 30679310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
    Maity TK; Venugopalan A; Linnoila I; Cultraro CM; Giannakou A; Nemati R; Zhang X; Webster JD; Ritt D; Ghosal S; Hoschuetzky H; Simpson RM; Biswas R; Politi K; Morrison DK; Varmus HE; Guha U
    Cancer Discov; 2015 May; 5(5):534-49. PubMed ID: 25735773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of Mig6 negatively regulates the ubiquitination and degradation of EGFR mutants in lung adenocarcinoma cell lines.
    Boopathy GTK; Lynn JLS; Wee S; Gunaratne J; Hong W
    Cell Signal; 2018 Mar; 43():21-31. PubMed ID: 29196224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells.
    Walsh AM; Lazzara MJ
    J Cell Sci; 2013 Oct; 126(Pt 19):4339-48. PubMed ID: 23868981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells.
    Siu A; Virtanen C; Jongstra J
    Oncotarget; 2011 Dec; 2(12):1134-44. PubMed ID: 22193779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription.
    Zhang H; Liu W; Wang Z; Meng L; Wang Y; Yan H; Li L
    Tumori; 2018 Jun; 104(3):221-231. PubMed ID: 29714661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TGFβ-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors.
    Izumchenko E; Chang X; Michailidi C; Kagohara L; Ravi R; Paz K; Brait M; Hoque MO; Ling S; Bedi A; Sidransky D
    Cancer Res; 2014 Jul; 74(14):3995-4005. PubMed ID: 24830724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor mutation in combination with expression of MIG6 alters gefitinib sensitivity.
    Naruo Y; Nagashima T; Ushikoshi-Nakayama R; Saeki Y; Nakakuki T; Naka T; Tanaka H; Tsai SF; Okada-Hatakeyama M
    BMC Syst Biol; 2011 Feb; 5():29. PubMed ID: 21333004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential parsing of EGFR endocytic flux among parallel internalization pathways in lung cancer cells with EGFR-activating mutations.
    Walsh AM; Lazzara MJ
    Integr Biol (Camb); 2014 Mar; 6(3):312-23. PubMed ID: 24445374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the interactions of EGFR with phosphorylated Mig6 by molecular dynamics simulations and MM-PBSA calculations.
    Zhang Y; Zheng QC
    J Theor Biol; 2018 Jun; 447():118-125. PubMed ID: 29574142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation.
    Ferby I; Reschke M; Kudlacek O; Knyazev P; Pantè G; Amann K; Sommergruber W; Kraut N; Ullrich A; Fässler R; Klein R
    Nat Med; 2006 May; 12(5):568-73. PubMed ID: 16648858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6.
    Park E; Kim N; Ficarro SB; Zhang Y; Lee BI; Cho A; Kim K; Park AKJ; Park WY; Murray B; Meyerson M; Beroukhim R; Marto JA; Cho J; Eck MJ
    Nat Struct Mol Biol; 2015 Sep; 22(9):703-711. PubMed ID: 26280531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNAJB1 destabilizes PDCD5 to suppress p53-mediated apoptosis.
    Cui X; Choi HK; Choi YS; Park SY; Sung GJ; Lee YH; Lee J; Jun WJ; Kim K; Choi KC; Yoon HG
    Cancer Lett; 2015 Feb; 357(1):307-315. PubMed ID: 25444898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of epidermal growth factor receptor is associated with MIG6 expression.
    Nagashima T; Ushikoshi-Nakayama R; Suenaga A; Ide K; Yumoto N; Naruo Y; Takahashi K; Saeki Y; Taiji M; Tanaka H; Tsai SF; Hatakeyama M
    FEBS J; 2009 Sep; 276(18):5239-51. PubMed ID: 19674104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells.
    Yoon YK; Kim HP; Song SH; Han SW; Oh DY; Im SA; Bang YJ; Kim TY
    Cancer Lett; 2012 Mar; 316(1):77-84. PubMed ID: 22082529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Tumor Suppressor MIG6 Controls Mitotic Progression and the G2/M DNA Damage Checkpoint by Stabilizing the WEE1 Kinase.
    Sasaki M; Terabayashi T; Weiss SM; Ferby I
    Cell Rep; 2018 Jul; 24(5):1278-1289. PubMed ID: 30067982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNAJB1/HSP40 Suppresses Melanoma Differentiation-Associated Gene 5-Mitochondrial Antiviral Signaling Protein Function in Conjunction with HSP70.
    Takashima K; Oshiumi H; Matsumoto M; Seya T
    J Innate Immun; 2018; 10(1):44-55. PubMed ID: 29069650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.